All In Biotech

Drug Trial Radar · NCT00567580

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy

Last checked: Nov 19, 2026Latest source record: May 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,792 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

1,792

Actual

Start

Feb 2008

Primary completion

Jul 12, 2018

Sponsor

Lead sponsor
Radiation Therapy Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); Cancer and Leukemia Group B; NRG Oncology
First posted
Dec 5, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as flutamide, bicalutamide, and luteinizing hormone-releasing hormone agonist, may lessen the amount of androgens made by the body. It is not yet known which regimen of radiation therapy with or without androgen-deprivation therapy is more effective for prostate cancer. PURPOSE: This randomized phase III trial is studying prostate radiation therapy to see how well it works compared with short-term androgen deprivation therapy given together with pelvic lymph node radiation therapy with or without prostate radiation therapy in treating patients with a rising PSA after surgery for prostate cancer.

Conditions

  • Prostate Cancer

Interventions

  • PBRTRadiation

    1.8 Gy per fraction once daily, 5 days a week totaling 64.8-70.2 Gy. 3D-CRT or IMRT required.

  • PLNRTRadiation

    1.8 Gy per fraction once daily, 5 days a week, totaling 45 Gy. 3D-CRT or IMRT required.

  • AADrug

    Antiandrogen (AA) therapy can be either 250 mg flutamide by mouth three times a day or 50 mg bicalutamide by mouth once a day.

  • LHRH agonistDrug

    Luteinizing hormone-releasing hormone (LHRH) agonist can be any analog approved by the FDA (or by Health Canada for Canadian institutions) and may be given in any possible combination such that the total LHRH treatment time is 4-6 months. LHRH analogs are administered with a variety of techniques, including subcutaneous insertion of a solid plug in the abdominal wall, intramuscular injection, and subcutaneous injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Free From Progression (FFP) at 5 YearsTime frame: From randomization to five years.

Locations

460 sites in 4 countries. Site status is shown where the registry gives one.

  • UAB Comprehensive Cancer Center

    Birmingham, Alabama

  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital

    Fairbanks, Alaska

  • Arizona Center for Cancer Care - Peoria

    Peoria, Arizona

  • Arizona Oncology Services Foundation

    Phoenix, Arizona

  • Arizona Oncology - Tucson

    Tucson, Arizona

  • Auburn Radiation Oncology

    Auburn, California

  • Peninsula Medical Center

    Burlingame, California

  • Radiation Oncology Centers - Cameron Park

    Cameron Park, California

  • Mercy Cancer Center at Mercy San Juan Medical Center

    Carmichael, California

  • East Bay Radiation Oncology Center

    Castro Valley, California

  • Valley Medical Oncology Consultants - Castro Valley

    Castro Valley, California

  • Enloe Cancer Center at Enloe Medical Center

    Chico, California

  • Valley Medical Oncology

    Fremont, California

  • Washington Township Hospital

    Fremont, California

  • California Cancer Center - Woodward Park Office

    Fresno, California

  • Cancer Care Associates

    Fresno, California

  • Rebecca and John Moores UCSD Cancer Center

    La Jolla, California

  • Veterans Affairs Medical Center - Long Beach

    Long Beach, California

  • Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

    Los Angeles, California

  • USC/Norris Comprehensive Cancer Center and Hospital

    Los Angeles, California

  • Contra Costa Regional Medical Center

    Martinez, California

  • Providence Holy Cross Cancer Center

    Mission Hills, California

  • Memorial Medical Center

    Modesto, California

  • El Camino Hospital Cancer Center

    Mountain View, California

  • Sutter Health - Western Division Cancer Research Group

    Novato, California

  • Alta Bates Summit Medical Center - Summit Campus

    Oakland, California

  • Bay Area Breast Surgeons, Incorporated

    Oakland, California

  • CCOP - Bay Area Tumor Institute

    Oakland, California

  • Larry G Strieff MD Medical Corporation

    Oakland, California

  • Tom K Lee, Incorporated

    Oakland, California

  • St. Joseph Hospital Regional Cancer Center - Orange

    Orange, California

  • Feather River Hospital Cancer Center

    Paradise, California

  • Radiation Oncology Center - Roseville

    Roseville, California

  • Radiological Associates of Sacramento Medical Group, Incorporated

    Sacramento, California

  • University of California Davis Cancer Center

    Sacramento, California

  • Mercy General Hospital

    Sacramento, California

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California

  • California Pacific Medical Center - California Campus

    San Francisco, California

  • Doctors Medical Center - San Pablo Campus

    San Pablo, California

  • Saint Helena Hospital

    St. Helena, California

Showing 40 of 460 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.